Skip Nav Destination
Issues
June 2019
-
Cover Image
Cover Image
In the latest issue of Neuronal Signaling (volume 3, issue 2), White et al. test the therapeutic efficacy of modulating collapsin response mediator protein 2 (CRMP2) activity via S-N-benzy-2-acetamido-3-methoxypropionamide ((S)-Lacosamide) on CLN6-Batten disease - a rare neurodegenerative disorder with no current cure. This cover features a representative image from their study, depicting classic Batten disease pathology in Cln6 mutant mouse brains.
EISSN 2059-6553
In this Issue
Review Article
The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
Neuronal Signal (2019) 3 (2): NS20180203.